Q1 2026 produced a structural fracture in synthetic biology: the cost of designing biological systems collapsed while the cost of producing them surged. Generative AI platforms made protein engineering accessible to any organization with a compute budget. The BIOSECURE Act began reshaping which supply chains are legally viable. Almost no organization mapped both shifts at once.